Brief: Brickell Says Nasdaq Granted Additional 180 Days To Regain Compliance With Requirement
14/12/2021 22:21
Dec 14 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH - GOT NOTICE FROM NASDAQ INFORMING CO
THAT
NASDAQ GRANTED CO AN ADDITIONAL 180 DAYS TO REGAIN COMPLIANCE
WITH REQUIREMENT
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx